BIONTECH SE - AMERICAN DEPOSITARY SHARES
122.68
04-October-24 15:59:59
15 minutes delayed
Stocks
+2.88
+2.40%
Today's range
119.68 - 124.14
ISIN
N/A
Source
NASDAQ
-
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
14 Aug 2023 06:45:00 By Nasdaq GlobeNewswire
-
BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update
07 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
BioNTech Completes Acquisition of InstaDeep
31 Jul 2023 08:00:00 By Nasdaq GlobeNewswire
-
BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC
29 Jun 2023 06:45:00 By Nasdaq GlobeNewswire
-
02 Jun 2023 06:45:00 By Nasdaq GlobeNewswire
-
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
08 May 2023 06:45:00 By Nasdaq GlobeNewswire
-
BioNTech to Report First Quarter 2023 Financial Results and Operational Update on May 8, 2023
24 Apr 2023 06:45:00 By Nasdaq GlobeNewswire
-
03 Apr 2023 06:45:00 By Nasdaq GlobeNewswire
-
BioNTech Announces New ADS Repurchase Program
28 Mar 2023 06:45:00 By Nasdaq GlobeNewswire
-
BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
27 Mar 2023 06:45:00 By Nasdaq GlobeNewswire
-
20 Mar 2023 07:45:00 By Nasdaq GlobeNewswire
-
13 Mar 2023 07:45:00 By Nasdaq GlobeNewswire
-
01 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
02 Feb 2023 06:45:00 By Nasdaq GlobeNewswire
-
10 Jan 2023 07:15:00 By Nasdaq GlobeNewswire
-
05 Jan 2023 19:01:00 By Nasdaq GlobeNewswire
-
BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference
28 Dec 2022 06:45:00 By Nasdaq GlobeNewswire
-
BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
23 Dec 2022 03:00:00 By Nasdaq GlobeNewswire
-
22 Dec 2022 06:00:00 By Nasdaq GlobeNewswire
-
Update on First BioNTainer for African-based mRNA Manufacturing Facility
21 Dec 2022 08:45:00 By Nasdaq GlobeNewswire